Search Within

Subhiksha Nandakumar

  1. "GSK Faculty"
Formats
  1. Journal Article (27)
  2. Meeting Abstract (21)
  3. Correspondence (1)
  4. Research Letter (1)
Groups
  1. GSK Faculty (50)
  2. Human Oncology and Pathogenesis Program (47)
  3. Department of Medicine (37)
  4. Solid Tumor Oncology Division (37)
  5. Department of Pathology and Laboratory Medicine (36)
  6. Epidemiology and Biostatistics (34)

More Groups

People
  1. Nikolaus Schultz (30)
  2. Michael Berger (22)
  3. David Solit (20)
  4. Ingo Mellinghoff (17)
  5. Angela Brannon (15)
  6. Marc Ladanyi (15)

More People

Years
  1. 2025 (4)
  2. 2024 (15)
  3. 2023 (8)
  4. 2022 (11)
  5. 2021 (2)
  6. 2020 (8)

More Years

Publications
  1. Clinical Cancer Research (9)
  2. Neuro-Oncology (7)
  3. Cancer Research (6)
  4. Journal of Clinical Oncology (6)
  5. Cancer Discovery (2)
  6. European Urology (2)

More Publications

Publishers
  1. American Association for Cancer Research (18)
  2. Oxford University Press (8)
  3. American Society of Clinical Oncology (6)
  4. Nature Publishing Group (5)
  5. Elsevier Inc. (2)
  6. Elsevier Science, Inc. (2)

More Publishers

Results (50)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combination olaparib and temozolomide for the treatment of glioma: A retrospective case series
    Journal Article

    Schaff, L. R.; Kushnirsky, M.; Lin, A. L.; Nandakumar, S.; Grommes, C.; Miller, A. M.; Gavrilovic, I. T.; Nolan, C.; Pentsova, E.; Mellinghoff, I. K.; more...
    Neurology (2022)

    Fulltext@MSK | Save
  • BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling
    Journal Article

    Shaashua, L.; Ben-Shmuel, A.; Pevsner-Fischer, M.; Friedman, G.; Levi-Galibov, O.; Nandakumar, S.; Barki, D.; Nevo, R.; Brown, L. E.; Zhang, W.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Genetic ancestry correlates with somatic differences in a real-world clinical cancer sequencing cohort
    Journal Article

    Arora, K.; Tran, T. N.; Kemel, Y.; Mehine, M.; Liu, Y. L.; Nandakumar, S.; Smith, S. A.; Brannon, A. R.; Ostrovnaya, I.; Stopsack, K. H.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer
    Journal Article

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Nguyen, B.; Stopsack, K. H.; Kreitzer, C.; Rajanala, S. H.; Ghale, R.; Mazzu, Y. Z.; Pillarsetty, N. V. K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Tumor MHC class I expression associates with intralesional IL2 response in melanoma
    Journal Article

    Pourmaleki, M.; Jones, C. J.; Ariyan, C. E.; Zeng, Z.; Pirun, M.; Navarrete, D. A.; Li, Y.; Zhang, M.; Nandakumar, S.; Campos, C.; more...
    Cancer Immunology Research (2022)

    Fulltext@MSK | Save
  • Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer
    Journal Article

    Mazzu, Y. Z.; Liao, Y. R.; Nandakumar, S.; Jehane, L. E.; Koche, R. P.; Rajanala, S. H.; Li, R.; Zhao, H. Y.; Gerke, T. A.; Chakraborty, G.; more...
    Oncogene (2022)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • Differences in prostate cancer genomes by self-reported race: Contributions of genetic ancestry, modifiable cancer risk factors, and clinical factors
    Journal Article

    Stopsack, K. H.; Nandakumar, S.; Arora, K.; Nguyen, B.; Vasselman, S. E.; Nweji, B.; McBride, S. M.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Identification and characterization of the PIK3R1-mutant subtype in PI3K-addicted prostate cancer
    Meeting Abstract

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Rajanala, S. H.; Nguyen, B.; Ghale, R.; Mazzu, Y. Z.; Jehane, L. E.; Lee, G. S. M.; Mucci, L. A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Integration of genomic and clinical data from 25,000 patients identifies molecular determinants of metastatic potential and organotropisms
    Meeting Abstract

    Nguyen, B.; Fong, C.; DiNatale, R.; Luthra, A.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Rajanna, A.; Solit, D. B.; Berger, M. F.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save